What Is the Role of Sedating Antidepressants, Antipsychotics, and Anticonvulsants in the Management of Insomnia?
- 17 August 2012
- journal article
- review article
- Published by Springer Nature in Current Psychiatry Reports
- Vol. 14 (5) , 494-502
Abstract
Psychiatric medications such as antidepressants, antipsychotics, and anticonvulsants are commonly prescribed by physicians for the off-label use of improving sleep. Reasons for preferential prescription of these medications over FDA-approved insomnia drugs may include a desire to treat concurrent sleep problems and psychiatric illness with a single medication, and/or an attempt to avoid hypnotic drugs due to their publicized side effects. However, there have been few large studies demonstrating the efficacy and safety of most off-label medications prescribed to treat insomnia. In addition, many of these medications have significant known side effect profiles themselves. Here we review the pertinent research studies published in recent years on antidepressant, antipsychotic, and anticonvulsant medications frequently prescribed for sleep difficulties. Although there have been few large-scale studies for most of these medications, some may be appropriate in the treatment of sleep issues in specific well-defined populations.Keywords
This publication has 72 references indexed in Scilit:
- Trazodone for sleep disturbance during methadone maintenance: A double-blind, placebo-controlled trialDrug and Alcohol Dependence, 2012
- Zolpidem Ingestion, Automatisms, and Sleep Driving: A Clinical and Legal Case SeriesJournal of Clinical Sleep Medicine, 2011
- Efficacy and Safety of Doxepin 3 and 6 mg in a 35-day Sleep Laboratory Trial in Adults with Chronic Primary InsomniaSLEEP, 2011
- Cognitive, psychomotor and polysomnographic effects of trazodone in primary insomniacsJournal of Sleep Research, 2011
- Trazodone plus pregabalin combination in the treatment of fibromyalgia: a two-phase, 24-week, open-label uncontrolled studyBMC Musculoskeletal Disorders, 2011
- A pooled analysis of two randomised, placebo-controlled studies of extended release quetiapine fumarate adjunctive to antidepressant therapy in patients with major depressive disorderJournal of Affective Disorders, 2010
- Trazodone for the treatment of fibromyalgia: an open-label, 12-week studyBMC Musculoskeletal Disorders, 2010
- Low-Dose DoxepinCNS Drugs, 2010
- A Double‐Blind Trial of Gabapentin Versus Lorazepam in the Treatment of Alcohol WithdrawalAlcohol, Clinical and Experimental Research, 2009
- Efficacy, Safety, and Tolerability of Pregabalin Treatment for Painful Diabetic Peripheral NeuropathyDiabetes Care, 2008